Absci (ABSI) Operating Margin Growth (3y) (2023 - 2026)
Absci (ABSI) Operating Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | -623.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 6,993.00 |
| 10 | Absci | 1.18 Bn | 1.06 Bn | - | -1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.24 Mn |
| Dec 31, 2025 | 144,659.00 |
| Sep 30, 2025 | -31,506.00 |
| Jun 30, 2025 | -241,100.00 |
| Mar 31, 2025 | 553,932.00 |
| Dec 31, 2024 | -569,907.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 18,884.00 |
| Mar 31, 2024 | -156,797.00 |
| Dec 31, 2023 | -720,424.00 |
| Sep 30, 2023 | -276,487.00 |
| Jun 30, 2023 | -77,781.00 |